STAR-TReC

  • Research type

    Research Study

  • Full title

    Can we Save the rectum by watchful waiting or TransAnal surgery following (chemo)Radiotherapy versus Total mesorectal excision for early REctal Cancer?

  • IRAS ID

    173279

  • Contact name

    Simon Bach

  • Contact email

    s.p.bach@bham.ac.uk

  • Sponsor organisation

    The University of Birmingham

  • Eudract number

    2016-000862-49

  • ISRCTN Number

    ISRCTN14240288

  • Duration of Study in the UK

    3 years, 0 months, 1 days

  • Research summary

    STAR-TREC is an international, multi-centre, randomised, phase II feasibility study comprising a 1:1:1 randomisation for eligible subjects with a small, clinically localised rectal cancer between; (a) conventional TME surgery, (b) organ saving utilising chemo radiation and (c) organ saving utilising short course preoperative radiotherapy

    The aim of the STAR-TREC study is to find the best way of treating a small rectal cancer. STAR-TREC will compare three different approaches. The “gold standard” treatment involves a large operation (called radical surgery) to remove the whole rectum. Two new approaches are designed to avoid the need for major surgery, we call these the “organ saving” treatments. These organ saving treatments use different types of radiotherapy to try and shrink the cancer as much as possible. How much the cancer shrinks will guide what happens next. In some patients the cancer disappears completely after radiotherapy and no further treatment is needed. In others a small lump remains after radiotherapy, and this is then removed by ‘keyhole’ surgery through the anus. Only the part of bowel wall affected by cancer is removed, most of the rectum and the anus are left alone. Finally, if the cancer does not shrink sufficiently we recommend that the patient has radical surgery to remove the rectum.
    While we believe that these new approaches are likely to have fewer side effects than the “gold standard” treatment, not many patients have received organ saving treatment, so we do not know if it will be as effective at curing cancer. In addition, some patients may have organ saving treatment and still need major surgery at some point.
    We will learn more about the new organ saving treatments such as how often treatment successfully saves the rectum, what side effects occur and how patients feel after treatment; particularly how well their bowels work.

  • REC name

    East Midlands - Leicester Central Research Ethics Committee

  • REC reference

    16/EM/0186

  • Date of REC Opinion

    23 Sep 2016

  • REC opinion

    Further Information Favourable Opinion